# FQ Restriction for the Prevention of CDI

> **NCT03848689** · — · COMPLETED · sponsor: **University of Wisconsin, Madison** · enrollment: 5871 (actual)

## Conditions studied

- Clostridium Difficile
- Clostridium Difficile Infection
- C Difficile Colitis

## Interventions

- **OTHER:** fluoroquinolone preprescription authorization
- **OTHER:** Control

## Key facts

- **NCT ID:** NCT03848689
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-01
- **Primary completion:** 2024-05-31
- **Final completion:** 2024-05-31
- **Target enrollment:** 5871 (ACTUAL)
- **Last updated:** 2025-01-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03848689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03848689, "FQ Restriction for the Prevention of CDI". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT03848689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*